Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PNRC2 pseudogene 3 (PNRC2P3) is a pseudogene related to the functional PNRC2 gene. Pseudogenes are non-coding segments of DNA that arise from previously functional genes but have lost their protein-coding ability or regulatory function, typically due to mutations. Therefore, PNRC2P3 is not a protein-coding gene, does not encode an active product, and is not considered a therapeutic target such as a receptor, enzyme, transporter, or other molecular drug target. There is no evidence that this pseudogene has biological function or direct involvement in disease, nor are there any reports linking it to drug interactions, mechanisms of action, or use as a biomarker. The functional PNRC2 gene (Proline-rich nuclear receptor coactivator 2) is involved in nuclear receptor-mediated transcription and mRNA decay processes. However, PNRC2P3 is separate from the canonical PNRC2 gene and instead classified as a pseudogene. If the intended target is PNRC2 (rather than its pseudogene), please specify, as PNRC2 itself is a well-characterized nuclear receptor coactivator and is associated with several biological processes. The designation "pseudogene" indicates the gene is not an active molecular target. The abbreviation "PNRC2P3" is valid for the pseudogene but not for the functional protein or receptor. No evidence currently supports a functional role or clinical significance for PNRC2 pseudogene 3. If you intended the functional nuclear receptor coactivator PNRC2 (not the pseudogene), please clarify for detailed target information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PNRC2 pseudogene 3 (PNRC2P3).